Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy

Recruiting now · Not applicable

Conditions studied: Facet Joint Arthropathy, Pain, Osteoarthritis

In brief

This single-site, single-arm study evaluates the feasibility, safety, tolerability, and efficacy of trans-arterial embolization (TAE) using Embozene microparticles for treating facetogenic pain due to facet arthropathy (osteoarthritis of the facet joints) in the lumbar spine.

Key facts

Study ID
NCT06965452
Run by
Northwell Health
People needed
40
Starts
2025-08-12
Expected to finish
2026-08-01
Last updated by the study team
2025-08-19

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.